Update of the guidelines for lupus anticoagulant detection

PENGO, V., TRIPODI, A., REBER, G., RAND, J.H., ORTEL, T.L., GALLI, M., DE GROOT, P.G.·2009·Journal of Thrombosis and Haemostasis
DOI 10.1111/j.1538-7836.2009.03555.x

Cited by (1,001)

Items 901–1,000 of 1,001

  1. Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome
    Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Luis Saez Comet, Ariadna Anunciación-Llunell, Raquel Ferrer‐Oliveras, Eleftheria Elmina Lefkou, Arsène MEKINIAN, Cristina C. Belizna, Ariela Hoxha, Anǵela Tincani et al. · 2026 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  2. Antiphospholipid Syndrome and Cardiovascular Disease
    Maania Naseem, Jaishkar Ramesh, Aysal Mahmood, Khushi Kothari, Fatimakhatun Memon, William H. Frishman, Wilbert S. Aronow · 2026 · Cardiology in Review
  3. Laboratory Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies
    Lucia R. Wolgast · 2018 · Elsevier eBooks
  4. Antiphospholipid syndrome with renal and splenic infarction after blunt trauma: A case report
    Na-A Lee, Eui-Sung Jeong, Hyunseok Jang, Yun Chul Park, Ji‐Hyoun Kang, Jung-Chul Kim, Young Goun Jo · 2022 · World Journal of Clinical Cases
  5. Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients
    Pavla Bradáčová, Luděk Slavík, Jana Úlehlová, Eva Kriegová, Eliška Jará, Lenka Bultasová, David Friedecký, Jana Ullrychová, Jana Procházková, Antonín Hluší et al. · 2023 · Biomedicines
  6. Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence
    Vittorio Pengo, Luca Sarti, Emilia Antonucci, Elisa Bison, Elena Pontara, Maria Grazia Cattini, Gentian Denas, Daniela Poli, Gualtiero Palareti · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
  7. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Rui Gao, Lang Qin · 2024 · 四川大学学报：医学版
  8. JAK inhibitors for the management of rheumatic diseases when antiphospholipid syndrome co-exists: case-based safety considerations
    S. Dans-Caballero, Irene Cecchi, Massimo Radin, Savino Sciascia · 2025 · Lupus
  9. Diagnosing Antiphospholipid Antibody Syndrome: A Review of the Criterion for Definite APS
    Jeffrey S. Dlott · 2015 · The Open Urology & Nephrology Journal
  10. Antiphospholipid Antibodies and Syndrome: Complexities in Diagnosis and Management
    Karen Ingrid Schreiber, Savino Sciascia, Beverley Jane Hunt · 2016 · Springer eBooks
  11. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell’s viper venom time and silica clotting time increases thrombotic risk prediction
    Youngeun Lee, J. Y. Gu, Hyun Kyung Kim · 2022 · Journal of Thrombosis and Thrombolysis
  12. A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications
    Maria Abbattista, Marco Capecchi, Francesca Gianniello, Andrea Artoni, Paolo Bucciarelli, Alessandro Ciavarella, Flora Peyvandi, Ida Martinelli · 2022 · Blood Coagulation & Fibrinolysis
  13. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT)
    Robert C. Gosselin · 2023 · Methods in molecular biology
  14. Mixing studies for lupus anticoagulant: does it matter how we mix?
    Vanja Radišić Biljak, Matea Tomas, Ivana Lapić · 2024 · Blood Coagulation & Fibrinolysis
  15. To normalize or not?: Dilute Russell viper venom time testing
    Yong Zhang, Michael H. Creer, Olajumoke O. Oladipo · 2024 · American Journal of Clinical Pathology
  16. Risk factors for cerebral infarction and cerebrovascular stenosis in antiphospholipid antibody-positive patients: A retrospective single-center study with propensity score matching analysis
    Seung Hyun Ha, Sang Uk Kim, Joon Huh, Choon-Woong Huh · 2024 · Medicine
  17. Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study
    Victoria O. Bitsadze, Mariya Gennadevna Nikolaeva, E. Mousty, Jamilya Kh. Khizroeva, Jérémy Laurent, Sylvie Ripart, Lorris Le Collen, Salim Allal, Mathieu Fortier, Sylvie Bouvier et al. · 2025 · European Journal of Internal Medicine
  18. Kaolin Clotting Time
    Kottayam Radhakrishnan · 2013 · Methods in molecular biology
  19. A Modified Mixing Test with a Proposed Cutoff Value to Screen for Clotting Factor Inhibitors
    Benjaporn Akkawat, Ponlapat Rojnuckarin · 2014 · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต)
  20. Antigen Specificity of Antiphospholipid Syndrome-Related Antiphospholipid Antibodies~!2009-09-28~!2009-11-02~!2010-03-11~!
    Ricardo R Forastiero · 2010 · The Open Autoimmunity Journal
  21. Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI)
    Armando Tripodi, Veena Chantarangkul, Vittorio Pengo · 2012 · Lupus
  22. [Hemorrhagic stroke: molecular mechanisms of pathogenesis and perspective therapeutic targets].
    А. Х. Хама-Мурад, Larisa I. Pavlinova, Anatoly A. Mokrushin · 2008 · PubMed
  23. Antiphospholipid syndrome
    Alan P. Martinez, Mark T. Cunningham · 2016 · Blood Coagulation & Fibrinolysis
  24. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma
    Pernille Just Vinholt, Mads Nybo · 2014 · Blood Coagulation & Fibrinolysis
  25. The Dilute Russell’s Viper Venom Time
    Kottayam Radhakrishnan · 2013 · Methods in molecular biology
  26. A diagnostic algorithm for the detection of inhibitors against coagulation Factor V
    Janne Cadamuro, Matthias Skocic, Burgi Meisl, Reinhard Bernd Raggam, Thomas Klaus Felder, Florian Prüller, Kathrin Reinstadler, Helmut Wiedemann, Cornelia Mrazek · 2015 · Clinical Chemistry and Laboratory Medicine (CCLM)
  27. Clinical Aspects of the Antiphospholipid Syndrome
    Aisha Lateef, Michelle Petri · 2012 · Elsevier eBooks
  28. Un tableau thrombo-hémorragique en rapport avec un syndrome hypoprothrombinémie – anticoagulant lupique révélant un myélome multiple à chaînes légères
    Hicham Eddou, Ali Zinebi, Abdelaziz Khalloufi, El Mehdi Mahtat, S.E. El Khadir, Mohamed Karim Moudden, Kamal Doghmi, Mohammed Mikdame, Mohammed El Baaj · 2018 · JMV-Journal de Médecine Vasculaire
  29. Pediatric Antiphospholipid Syndrome
    Tadej Avčin, Rolando Cimaz · 2016 · Technical report
  30. Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive?
    Matthew R. Kovacs, Alejandro Lazo‐Langner, Michael J. Kovacs · 2020 · Thrombosis Research
  31. Síndrome antifosfolipídico
    Nathalie Costedoat-Chalumeau, Nathalie Morel · 2019 · EMC - Aparato Locomotor
  32. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases
    Javier Pagán Escribano, Javier Corral, Antonia Miñano, José Padilla, Vanessa Roldán, M J Hernández-Vidal, Jesús Lozano, Isabel de la Morena Barrio, Vicente Vicente, Marı́a Luisa Lozano et al. · 2023 · International Journal of Molecular Sciences
  33. Perioperative Management of Antiphospholipid Antibody Positive Patients During Noncardiac Surgeries
    Katherine H. Saunders, Doruk Erkan · 2012 · Springer eBooks
  34. Laboratory Criteria of Antiphospholipid Syndrome Need to be Updated or Strictly Followed?~!2009-09-24~!2009-09-28~!2010-03-11~!
    Marta Elba Martinuzzo · 2010 · The Open Autoimmunity Journal
  35. Prevalence and Significance of Persistently Positive Antiphospholipid Antibodies in Women with Preeclampsia
    Cristina González-Echávarri, Irama Villar, Amaia Ugarte, Rosa Larrieta, Guillermo Ruiz‐Irastorza · 2014 · The Journal of Rheumatology
  36. Standardization of sample preparation for clotting time assays
    Yutaka Komiyama · 2016 · Japanese Journal of Thrombosis and Hemostasis
  37. Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study
    Franz Ratzinger, Tanja Panić‐Janković, Helmuth Haslacher, Thomas Perkmann, Klaus G. Schmetterer, Sabine Belik, Georg Maenner, Ingrid Pabinger, Peter Quehenberger · 2017 · Biochemia Medica
  38. Magnesium‐dependent activated partial thromboplastin time assay—Simple method for lupus anticoagulant detection
    Takayoshi Tokutake, Masahiro Ieko, Sumiyoshi Naito, Mika Yoshida, Hisami Baba, Hikaru Kobayashi, Fumihiro Ishida · 2019 · International Journal of Laboratory Hematology
  39. Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome
    Paul R. J. Ames, Mira Merashli, Tommaso Bucci, Luigi Iannaccone, Vincenzo Marottoli, Antonio Ciampa · 2020 · International Journal of Hematology
  40. Antiphospholipid Syndrome
    Thomas L. Ortel, Doruk Erkan, Michael D. Lockshin · 2019 · Elsevier eBooks
  41. Antiphospholipid-Syndrom bei Kindern und Jugendlichen
    Christian Michael Hedrich, Tilmann Kallinich · 2022 · Springer Reference Medizin
  42. Hemostatic disturbances in acute ischemic stroke
    Elisabeth Rooth · 2011 · Figshare
  43. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment
    Vittorio Pengo · 2016 · Journal of Thrombosis and Haemostasis
  44. Examens biologiques en pathologie articulaire auto-immune
    Olivier Meyer · 2013 · Time to knit
  45. Determining the cut-off value of the APTT mixing test for factor VIII inhibitor: reply
    Osamu Kumano, Masahiro Ieko · 2019 · Clinical Chemistry and Laboratory Medicine (CCLM)
  46. Response to: ‘Presence of anti-phospholipid antibodies in COVID-19: a case series study’ by Amezcua-Guerra et al
    Alexis Mathian, Marc Pineton de Chambrun, Alain Combes, Zahir Amoura · 2020 · Annals of the Rheumatic Diseases
  47. Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer
    Brian H. Shirts, George M. Rodgers, Kristi Johnson Smock · 2012 · Thrombosis Research
  48. Modern approaches to diagnostics of Antiphospholipid syndrome
    Anna L. Amosova, I. V. Goncharova, D. S. Arkhipov · 2016 · Laboratory Service
  49. A 31-Year-Old Woman with Consecutive Pregnancy Losses
    Yanhong Zhai, Wei Song, Jiazi Zeng, Zhen Zhao, Zheng Cao · 2018 · Clinical Chemistry
  50. Antiphospholipid antibodies in the obstetric antiphospholipid syndrome: Detection and antibodies profile at the Maternity and Neonatal Medicine Center of Monastir, Tunisia
    Linda Khefacha, Rania Rassas, Haifa Bergaoui, Henda Mustapha, Raja Faleh, Nabil Sakly, Mouna Sassi · 2022 · Journal of obstetrics and gynaecology research
  51. A Case of Antiphospholipid Syndrome and Protein C Deficiency due to PROC Gene Mutation
    Hao Thai Phan · 2024 · International Journal of Advanced Multidisciplinary Research and Studies
  52. Lupus anticoagulant and valvular cardiac surgery
    Pooja Bola Rajendra Devendra Kamath, Deborah L Braham, Deepa J. Arachchillage, Daniela Cristina Velecela Loja · 2024 · Perfusion
  53. Adjusted Global Antiphospholipid Syndrome Score Is Associated with End-Stage Kidney Disease in Patients with ANCA-Associated Vasculitis: A Single-Centre Pilot Study
    Pil Gyu Park, Hyun Joon Choi, Yong‐Beom Park, Sang‐Won Lee · 2025 · Yonsei Medical Journal
  54. Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study
    Edward Itelman, Maxim Perelman, Natali Bivar, Daniella Kent, Adva Vaisman, Gad Segal, Liat Negru, Amir Dagan · 2023 · Lupus
  55. Determination of the 99th percentile of anticardiolipin and anti-β2 glycoprotein I antibodies in an institution in the city of Medellin, Colombia
    Gustavo Adolfo Castilla-Agudelo, Libia María Rodríguez Padilla, Sergio Velásquez, Lady Johanna Hernández Zapata, Miguel Antonio Mesa Navas, María Fernanda Álvarez Barreneche, Carlos Jaime Velásquez Franco · 2024 · Revista Colombiana de Reumatología (English Edition)
  56. Standardization of the detection for lupus anticoagulant
    Osamu Kumano, Sumiyoshi Naito, Satoshi Yamazaki, Masahiro Ieko · 2024 · Japanese Journal of Thrombosis and Hemostasis
  57. Laboratory Profile of Lupus Anticoagulant Positive Cases and its Association with Clinical Presentation- Experience from a Tertiary Care Centre in Southern India
    Pranav Raghuram, Mithraa Devi Sekar, Lokeshwari Srinivasan, Prabhu Manivannan, Debdatta Basu, Rakhee Kar · 2024 · Indian Journal of Hematology and Blood Transfusion
  58. Enhancing Lupus Anticoagulant Testing with Machine Learning: Deep Neural Networks Match Expert Performance without the Need for Feature Selection
    Jeffrey Y. Wang, Rachel R. Leger, Dong Chen, Jansen N. Seheult · 2025 · The Journal of Applied Laboratory Medicine
  59. Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome
    Ana Marco, Ihosvany Fernández Bello, Jorge Mateo-Sotos, Pascual Marco · 2025 · Research and Practice in Thrombosis and Haemostasis
  60. The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with APS
    H. Moriya, Ryo Hisada, Yuichiro Fujieda, Michihito Kono, Olga Amengual, Masaru Kato, Kazufumi Okada, Yoichi Minagawa Ito, Tatsuya Atsumi · 2025 · Rheumatology
  61. Lupus Anticoagulant and Complement C4 Consumption in Antiphospholipid Antibody Testing: Disentangling Inflammation From Autoimmunity
    Nikolaos E. M. Androulakis, Olga Striligka, Eleni Nioti, Antonios Dilintas, Aikaterini Darivianaki, Anastasia Papadopoulou, Fotini Nistikaki, Theodosia Iatridi, Marilena Kampa, Christina H. Kalpadakis · 2026 · International Journal of Laboratory Hematology
  62. Updates in Antiphospholipid Syndrome Laboratory Diagnosis
    Geoffrey D. Wool · 2026 · Clinics in Laboratory Medicine
  63. "Indeterminate lupus anticoagulant" as the third category
    Sang Hyuk Park, Seongsoo Jang · 2012 · The Korean Journal of Hematology
  64. A 77-Year-Old Man with a Prolonged Activated Partial Thromboplastin Time
    Martin Ehrenschwender, Juergen Koessler, Kirsten Brunner, Udo Steigerwald · 2012 · Clinical Chemistry
  65. Étapes préanalytiques en hémostase
    Jean‐Christophe Gris · 2011 · EMC - Biologie Médicale
  66. Evaluation of Kaolin Clotting Time for the Diagnosis of Lupus Anticoagulants by Using Different Calculation Methods
    Katcharin Aryurachai, Pantep Angchaisuksiri, Kanchana Siriputtanapong · 2014 · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต)
  67. Post-surgical hemorrhagic infarction of the adrenal gland as the first clinical manifestation of antiphospholipid syndrome after 43 years of antibody-positivity
    Johanna Haselböck, Helmut Ringl, Catharina Mueller, Ingrid Pabinger, Stefan Winkler · 2012 · Modern Rheumatology
  68. Reactivity against the Five Domains of β2 Glycoprotein I: A Focus on Systemic Lupus Erythematosus
    Cecilia Beatrice Chighizola · 2014 · Journal of Clinical & Cellular Immunology
  69. Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them
    Ning Tang, Ziyong Sun, Shiyu Yin · 2016 · Clinical Chemistry and Laboratory Medicine (CCLM)
  70. Contemporary Prevention and Treatment of Recurrent Pregnancy Loss
    Mayumi Sugiura‐Ogasawara, Yasuhiko Ozaki, Kinue Katano, Tamao Kitaori · 2016 · Springer eBooks
  71. Antiphospholipid Syndrome Antibodies — Snippets from the Laboratory
    Justin Hung Tiong Tan, Cecilia Cheng Lai Ngan, Thaschawee Arkachaisri · 2013 · Proceedings of Singapore Healthcare
  72. Diagnosis of antiphospholipid syndrome: From an historical perspective to the emergence of new autoantibodies
    Oscar Ardila-Suarez, José Alfredo Gómez-Puerta, Munther A. Khamashta · 2016 · Medicina Clínica (English Edition)
  73. A 75-year-old with abdominal pain, hypoxia, and weak pulses in the left leg
    Maya Serhal, Natalie Evans, Heather L. Gornik · 2018 · Cleveland Clinic Journal of Medicine
  74. Allongement du temps de céphaline avec activateur
    Leyla Calmette, Georges Jourdi, Emmanuel de Maistre, M.-F. Hurtaud, Isabelle Gouin‐Thibault, Virginie Siguret, Groupe français d'études sur l'hémostase et la thrombose · 2017
  75. Clinical Aspects of Antiphospholipid Syndrome
    Laura Durcan, Michelle Petri · 2019 · Elsevier eBooks
  76. Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins
    Aleksandra Djoković, Ljudmila Stojanovich, Nataša Stanisavljević, M Popovic, Marija D. Zdravkovic · 2020 · Lupus
  77. Antiphospholipid Antibodies and Fertility: No Impact on Ovarian Reserve in Premenopausal Women
    Savino Sciascia, Massimo Radin, Elisa Menegatti, Alice Barinotti, Federica Sini, Irene Cecchi, Elena Rubini, Foddai Silvia, Roccatello Dario · 2020 · Journal of Clinical Rheumatology and Immunology
  78. Lupus anti-coagulant (LA) screening & confirmation testing by dilute Russell viper venom time (DRVVT) method
    Pramod Kumar Pamu · 2020 · International Journal of Clinical and Diagnostic Pathology
  79. Arterial and Venous Thrombosis as a Symptom of Antiphospholipid Syndrome – A Noticeable Analysis from the Past.
    Agata Kopydłowska, Ewelina Wojtasińska, Jolanta Kurosz, Krystyna Zawilska, Lidia Gil · 2021 · Medical Research Archives
  80. Anti-phospholipid antibodies in the setting of thromboembolic events associated with severe COVID-19 pneumonia
    Omaima Ibrahim Badr, Wael Aly Elrefaey, Mohammed Hassan Abu-Zaid, Samah Hamdy Elmedany · 2022 · Egyptian Rheumatology and Rehabilitation
  81. Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients
    Mirjana K. Kovac, Dusica Basaric, Branko Tomić, Maja Gvozdenov, Dragana Bačković, Sanja Lalic‐Cosic · 2021 · Vojnosanitetski pregled
  82. Antiphospholipid Syndrome and Stroke
    Kathryn Grimes, Adam P. Klein, Rakhee Lalla, Adeolu Morawo, Sana Somani, Mathew J. Woodward, John W. Cole · 2022 · IntechOpen eBooks
  83. Antiphospholipid syndrome
    Munther A. Khamashta, Silvia S. Pierangeli, E. Nigel Harris · 2011 · Elsevier eBooks
  84. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis
    Aleksandra Djoković, Ljudmila Stojanovich, Nataša Stanisavljević, Predrag Matić, D. Colic, Daniel Škrijelj, Sandra Djokic, Branka F. Filipović · 2022 · JCR Journal of Clinical Rheumatology
  85. Bedeutung von Quick, partieller Thromboplastinzeit und Co.
    Gabriele Siegert · 2014 · Der Internist
  86. Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome
    Murat Çağan, Hanife Güler Dönmez, Z. Günnur Dikmen, Mehmet Sinan Beksaç · 2023 · Human Antibodies
  87. Modulation of the activation of endothelial nitric oxide synthase and nitrosative stress biomarkers by aspirin triggered lipoxins: A possible mechanism of action of aspirin in the antiphospholipid syndrome
    Manuel Granada‐Gómez, Manuela Velásquez, Carolina Rúa-Molina, Sebastián San Martín, Carlos Escudero, Ángela M. Álvarez, Ángela Patricia Cadavid · 2023 · American Journal of Reproductive Immunology
  88. The lupus anticoagulant titer is associated with elevated antiphosphatidylserine/prothrombin immunoglobulin‐M isotype antibody levels
    Abdulrahman M. Saadalla, Dong Chen, Melissa Stuart, Rajiv K. Pruthi, Nahla Heikal, Melissa R. Snyder, Aneel A. Ashrani, Jansen N. Seheult · 2024 · International Journal of Laboratory Hematology
  89. Laboratory assessment of antiphospholipid syndrome: Laboratory data
    Camilla Jannie Kobylecki, Signe Vedel‐Krogh, Shoaib Afzal, Jens Peter Goetze · 2024 · International Journal of Laboratory Hematology
  90. Budd Chiari syndrome associated with antiphospholipid syndrome: Clinical characteristics and prognosis of 17 patients from single center
    Ömer Uludağ, Akın Işık, Ege Sinan Torun, Burak Alkaç, Yasemin Yalçınkaya, Ahmet Gül, Murat İnanç, Sabahattin Kaymakoğlu, Bahar Artım-Esen · 2025 · Lupus
  91. Lupus anticoagulant testing in Belgian laboratories: a comparison with the 2020 International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (ISTH-SSC) guidelines
    Bénédicte Vanhove, Lieve Van Hoovels, Sylvia Broeders, Wim Coucke, Marco W.J. Schreurs, Carolien Bonroy, Sofie Schouwers, Robin Vanstokstraeten, Els Bailleul, Katrien M.J. Devreese · 2025 · Acta Clinica Belgica
  92. Antiphospholipid Syndrome: Changing Knowledge During the Time – The ”Four P” Pattern
    Alena Buliková · 2012 · InTech eBooks
  93. Determinación de valores cut-off en donantes sanos para el protocolo de detección de anticoagulante lúpico, en el Laboratorio Médico Echavarría según Guías Internacionales
    Maribel Saldarriaga Saldarriaga, Mary Alejandra Restrepo Lozada, Gloria Patricia Montoya-López · 2014 · Revista Latinoamericana de Patología Clínica y Medicina de Laboratorio
  94. Fausses couches spontanées et morts fœtales in utero liées à des anomalies de l’hémostase
    Denis Massignon · 2010 · Revue Francophone des Laboratoires
  95. Chronic Headache with Unusual Episode: A Case of Cerebral Venous Sinus and Extracranial Venous Thrombosis in Antiphospholipid Syndrome
    Chaw Su Naing, Wan Tin Lim, Slapak Gabrielle, Balakrishnan Tharmmambal · 2014 · OALib
  96. A routine silica‐based activated partial thromboplastin time (Hemosil aPTT‐SP™) mostly excludes the presence of lupus anticoagulant
    Antonella Mameli, Doris Barcellona, Maria Luigia Vannini, Francesco Marongiu · 2011 · International Journal of Laboratory Hematology
  97. Laboratory Methodology Important in the Diagnosis and Prognosis of Antiphospholipid Syndrome
    Polona Žigon, Mojca Božič Mijovski, Mojca Frank‐Bertoncelj, Aleš Ambrožič, Matija Tomšič, Alojzija Hočevar, Borut Božič, Snežna Sodin Šemrl, Tanja Kveder, Saša Čučnik · 2015 · InTech eBooks
  98. Laboratory Analysis of Coagulation
    Heesun Joyce Rogers, Suzanne Bakdash, Megan O. Nakashima, Kandice Kottke‐Marchant · 2013 · Springer eBooks
  99. Current practices for lupus anticoagulant testing at a tertiary care hospital and impact on laboratory resources
    Mansour S. Aljabry · 2015 · Annals of Saudi Medicine
  100. Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)
    Robert C. Gosselin, Jonathan Douxfils, Dorothy M. Adcock · 2018 · Phlebologie